|
|
|
|
|
|
Bristol-Myers Squibb Company (BMY)
|
|
56.64 -0.69 (-1.20%)
|
6/23/2017 4:00pm
|
|
Open:
|
57.27
|
Pre. Close:
|
57.33
|
|
High:
|
57.36
|
Low:
|
56.24
|
|
Volume:
|
1
|
Market Cap:
|
93.31B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
57.47 - 57.89
|
57.89 - 58.21
|
|
Low:
|
55.46 - 55.84
|
55.84 - 56.14
|
|
Close:
|
56.22 - 56.75
|
56.75 - 57.17
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:32:44 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 67.63 One year: 78.99
|
|
Support:
|
Support1: 53.98 Support2: 51.56
|
|
Resistance:
|
Resistance1:
57.90 Resistance2: 67.63
|
|
Pivot:
|
54.46 
|
|
Moving Averages:
|
MA(5): 56.18 MA(20): 54.35
MA(100): 54.34 MA(250): 56.75
|
|
MACD:
|
MACD(12,26):
0.54 Signal(12,26,9): 0.13
|
|
%K %D:
|
%K(14,3): 86.99 %D(3): 88.53
|
|
RSI:
|
RSI(14): 63.07
|
|
52-Week:
|
High: 77.12
Low: 46.01 Change(%): -20.0
|
|
Average Vol(K):
|
3-Month: 522483
10-Days 6856
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.BMY has closed below upper band by 15.2%. Bollinger Bands are 33.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Wed, 14 Jun 2017 12:06:11 GMT
Bristol-Myers Squibb: Still Too Many Uncertainties In The I/O Space
Mon, 19 Jun 2017 21:32:20 GMT
Bristol-Myers Squibb Is Poised for a Breakout
Fri, 02 Jun 2017 11:15:00 GMT
Bristol-Myers Squibb reports data from phase 1/2 trial for cancers associated ...
Wed, 07 Jun 2017 12:00:00 GMT
Bristol-Myers Fails To Stem The Losses
Tue, 20 Jun 2017 19:40:33 GMT
Bristol-Myers Squibb Announces the Pricing Terms of its Cash Tender Offer For ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
